Sector valuations VYNE Therapeutics Inc.

Equities

VYNE

US92941V3087

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2025-02-14 pm EST			5-day change	1st Jan Change
2.470 ^USD	-0.60%		+2.49%	-26.27%

Jan. 06	VYNE Therapeutics Completes Enrollment in Phase 2B Trial Evaluating Vyn201 for the Treatment of Nonsegmental Vitiligo	CI
Dec. 23	VYNE Therapeutics Reports 'Positive' Phase 1a Results for VYN202 Inhibitor	MT

Sector:

Location:

X axis:

Main competitors

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E ratio (Y)	Price to Book (Y)	PEG (Y)	EV / Sales (Y)	EV / EBITDA (Y)	EV / EBIT (Y)	Yield (Y)	Capi.($)
VYNE THERAPEUTICS INC.	-2.57x	-	0.04x	-	-	-	-	36.44M
VERTEX PHARMACEUTICALS INCORPORATED	28.97x	6.09x	-0.03x	8.79x	18.55x	19.19x	-.--%	118B
REGENERON PHARMACEUTICALS, INC.	18.18x	2.23x	-5.4x	4.08x	11.46x	12.08x	0.42%	72.09B
ARGENX SE	452.74x	8.55x	-3.53x	16.36x	-806.02x	-741.32x	-.--%	38.79B
BIONTECH SE	-34.78x	1.41x	0.19x	5.43x	-11.66x	-9.8x	-.--%	28.73B
BEIGENE, LTD.	-41.51x	7.33x	1.21x	6.16x	-43.81x	-35.86x	-.--%	24.63B
WUXI APPTEC CO., LTD.	18.12x	2.8x	13.97x	4.1x	11.67x	14.34x	1.66%	23.61B
SUMMIT THERAPEUTICS INC.	-67.52x	-	0.99x	-	-	-	-	15.76B
INSMED INCORPORATED	-14.78x	46.51x	-30.99x	40.82x	-17.64x	-17.37x	-.--%	14.19B
GENMAB A/S	14.01x	2.14x	-1.21x	2.85x	8.16x	9.16x	-.--%	13.46B
WUXI BIOLOGICS (CAYMAN) INC.	27.2x	2x	7.42x	4.63x	13.77x	18.68x	-.--%	12.26B
NEUROCRINE BIOSCIENCES, INC.	26.1x	3.41x	0.77x	3.65x	18.55x	18.95x	-.--%	11.47B
VAXCYTE, INC.	-20.65x	-	11.93x	-	-17.08x	-16.54x	-.--%	10.47B
SAREPTA THERAPEUTICS, INC.	40.21x	7.43x	-0.27x	5.2x	36.5x	53.21x	-.--%	10.31B
EXELIXIS, INC.	17.3x	3.55x	1.16x	4.18x	12.73x	14.16x	-.--%	9.8B
ASCENDIS PHARMA A/S	-41.93x	-31.19x	0.84x	15.56x	-39.64x	-49.17x	-.--%	8.62B
PHARMAESSENTIA CORPORATION	91.26x	9.37x	-0.17x	24.72x	134.83x	133.2x	0.34%	7.8B
ZEALAND PHARMA A/S	-58.51x	5.57x	-16.99x	141.43x	-53.24x	-47.92x	-.--%	7.49B
MADRIGAL PHARMACEUTICALS, INC.	-14.38x	10.91x	-0.83x	37.38x	-12.05x	-12.16x	-.--%	7.35B
Average	23.02x	5.51x	-1.10x	20.33x	-43.23x	-37.48x	percentage-no-prefix	22.88B
Weighted average by Cap.	46.96x	5.60x	-1.15x	11.85x	-68.28x	-60.74x	percentage-no-prefix

Bio Therapeutic Drugs